Clinical Trial Update: Carmustine Implants in Treating Patients With Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Carmustine implants for brain metastases has completed, coordinated by the New Approaches to Brain Tumor Therapy Consortium.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• GLIADEL wafer (carmustine)

Snippet

Sponsor: New Approaches to Brain Tumor Therapy Consortium | Conditions: Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Phase 2 | Status: COMPLETED